TELA Bio, Inc. (TELA) Operating margin 2017–2025
TELA Bio, Inc. (TELA) operating margin by fiscal year — reported operating income divided by reported revenue.
-42.0%FY2025 · since FY2017: -398.7% → -42.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -42.0% | +7.2 pp |
| FY2024 | -49.2% | +26.2 pp |
| FY2023 | -75.4% | +18.8 pp |
| FY2022 | -94.2% | +5.8 pp |
| FY2021 | -100.0% | +38.8 pp |
| FY2020 | -138.8% | -14.7 pp |
| FY2019 | -124.1% | +90.9 pp |
| FY2018 | -214.9% | +183.8 pp |
| FY2017 | -398.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TELA financial trends
TELA RevenueTELA Net incomeTELA Net marginTELA Gross profitTELA Gross marginTELA Operating incomeTELA Operating cash flowTELA Free cash flowTELA Capital expendituresTELA Return on equityTELA Stock buybacksTELA Dividends paidTELA Total assetsTELA Total liabilitiesTELA Shareholders’ equityTELA overview →